NATIONAL BANK OF CANADA /FI/ - INTELLIA THERAPEUTICS INC ownership

INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 369 filers reported holding INTELLIA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 1.08 and the average weighting 0.2%.

Quarter-by-quarter ownership
NATIONAL BANK OF CANADA /FI/ ownership history of INTELLIA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$728
+19.1%
25
+66.7%
0.00%
Q2 2023$611
+9.3%
150.0%0.00%
Q1 2023$559
+6.9%
150.0%0.00%
Q4 2022$523
-98.7%
15
-97.9%
0.00%
Q3 2022$39,000
+129.4%
700
+192.9%
0.00%
Q1 2022$17,000
-50.0%
239
-17.3%
0.00%
Q4 2021$34,0002890.00%
Other shareholders
INTELLIA THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
HIMENSION CAPITAL (SINGAPORE) PTE. LTD. 1,216,340$62,958,0007.04%
Discovery Value Fund 584,483$30,253,0006.33%
MPM BioImpact LLC 299,409$15,497,0004.30%
ARK Investment Management 9,514,580$439,003,0002.60%
Elmwood Wealth Management, Inc. 67,899$3,514,0002.00%
Nikko Asset Management Americas, Inc. 2,781,136$141,143,0001.74%
Avidity Partners Management LP 1,125,194$58,240,0001.34%
Merlin Capital, Inc 12,174$630,0001.26%
Atlas Venture Associates IX, LLC 10,000$518,0001.18%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 111,440$5,768,0001.16%
View complete list of INTELLIA THERAPEUTICS INC shareholders